A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT)
Not Applicable
Completed
- Conditions
- Actinic Keratoses
- Interventions
- Procedure: Photodynamic therapy with methyl aminolevulinate
- Registration Number
- NCT00711178
- Lead Sponsor
- Bispebjerg Hospital
- Brief Summary
A randomised, multi-center study of daylight mediated photodynamic therapy (PDT) with Metvix in patients with multiple actinic keratosis on the face and/or scalp.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- 18 years and older, 5 AK in face and scalp
Exclusion Criteria
- immunosuppression
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description A Photodynamic therapy with methyl aminolevulinate 2 hours sunlight B Photodynamic therapy with methyl aminolevulinate 3 hours of sunlight
- Primary Outcome Measures
Name Time Method response rate 3 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Bispebjerg Hospital
🇩🇰Copenhagen, Denmark